Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Cancer Discov. 2020 Dec 4;11(3):626–637. doi: 10.1158/2159-8290.CD-20-1579

Table 1.

Pretreatment characteristics of younger (<60 years) and older (≥60 years) non-Hispanic Black and White patients diagnosed with acute myeloid leukemia (AML) included in SEER registries in 1986–2015

Characteristic Younger patients Older patients
Black
n=1,356
White
n=8,074
Pa Black
n=1,258
White
n=14,835
Pa
Age, years <0.001 <0.001
 Median 45 48 72 73
 Range 18–59 18–59 60–85 60–85
Sex, n (%) 0.09 <0.001
 Male 700 (52) 4,368 (54) 609 (48) 8,394 (57)
 Female 656 (48) 3,706 (46) 649 (52) 6,441 (43)
Metro, n (%) <0.001 <0.001
 Yes 1,272 (94) 7,124 (88) 1,170 (93) 12,849 (87)
 No 84 (6) 950 (12) 88 (7) 1986 (13)
Insurance, n (%) <0.001 <0.001
 Insured 375 (28) 2,604 (32) 466 (37) 5,596 (38)
 Any Medicaid 218 (16) 527 (7) 104 (8) 340 (2)
 Uninsured 58 (4) 130 (2) 13 (1) 67 (0.5)
 Insurance status unknown 705 (52) 4,813 (60) 675 (54) 8,832 (59.5)
Percent of families below poverty level <0.001 <0.001
 Median 13% 8% 13% 9%
 Range 3%−42% 2%−37% 2%−31% 2%−42%
Year of diagnosis, n (%) <0.001 0.002
 1986–1995 160 (12) 1,365 (17) 164 (13) 2,335 (16)
 1996–2005 480 (35) 2,994 (37) 439 (35) 5,478 (37)
 2006–2015 716 (53) 3,715 (46) 655 (52) 7,022 (47)
a

P-values for categorical variables are from Fisher’s exact test, P-values for continuous variables are from the Wilcoxon rank sum test.